Next Article in Journal
Co-Amorphous Solid Dispersion System for Improvement in Dissolution Profile of N-(((1r,4r)-4-((6-fluorobenzo[d]oxazol-2-yl)amino)cyclohexyl)methyl)-2-methylpropane-2-sulfonamide as a Neuropeptide Y5 Receptor Antagonist
Previous Article in Journal
Synthesis, Characterization, Bioavailability and Antimicrobial Studies of Cefuroxime-Based Organic Salts and Ionic Liquids
 
 
Article

Article Versions Notes

Pharmaceutics 2024, 16(10), 1292; https://doi.org/10.3390/pharmaceutics16101292
Action Date Notes Link
article pdf uploaded. 2 October 2024 11:17 CEST Version of Record https://www.mdpi.com/1999-4923/16/10/1292/pdf-vor
article pdf uploaded. 2 October 2024 11:30 CEST Updated version of record https://www.mdpi.com/1999-4923/16/10/1292/pdf-vor
article supplementary file uploaded. 2 October 2024 11:30 CEST - https://www.mdpi.com/1999-4923/16/10/1292#supplementary
article xml file uploaded 8 October 2024 10:31 CEST Original file -
article xml uploaded. 8 October 2024 10:31 CEST Update https://www.mdpi.com/1999-4923/16/10/1292/xml
article pdf uploaded. 8 October 2024 10:31 CEST Updated version of record https://www.mdpi.com/1999-4923/16/10/1292/pdf
article html file updated 8 October 2024 10:34 CEST Original file https://www.mdpi.com/1999-4923/16/10/1292/html
Back to TopTop